Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 19, 2002 - Issue 5
Submit an article Journal homepage
1,534
Views
96
CrossRef citations to date
0
Altmetric
Research Article

DEXTROMETHORPHAN IS EFFECTIVE IN THE TREATMENT OF SUBACUTE METHOTREXATE NEUROTOXICITY

Richard A. Drachtman Cancer Institute of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
,
Peter D. Cole Cancer Institute of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
,
Carla B. Golden Children's Hospital Oakland, Oakland, California, USA
,
S. Jill James Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arizona, USA
,
Stepan Melnyk Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arizona, USA
,
Joseph Aisner Cancer Institute of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
&
Barton A. Kamen Cancer Institute of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
 show all
Pages 319-327 | Published online: 09 Jul 2009

  • Mahohey DH Jr, Shuster JJ, Nitschke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy: a Pediatric Oncology Group study. J Clin Oncol. 1998;16:1712-1722.
  • Quinn CT, Kamen BA. A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities. J Invest Med. 1996;44:522-530.
  • Quinn CT, Griener JC, Bottiglieri T, Hyland K, Farrow A, Kamen BA. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol. 1997;15:2800-2806.
  • Bellamy MF, McDowell IFW. Putative mechanisms for vascular damage by homocysteine. J Inher Metab Dis. 1997;20:307-315.
  • Welch GH, Loscalzo J. Homocysteine and atherothrombosis. New Engl J Med. 1998;335:1042-1050.
  • Do KQ, Herrling PL, Streit P, Cuenod M. Release of neuractive substances: homocysteic acid as an endogenous agonist of the NMDA receptor. J Neural Transm. 1988;72:185-190.
  • Griffiths R. Cysteine sulphinate (CSA) as an excitatory amino acid transmitter candidate in the mammalian central nervous system. Prog Nurobiol. 1990;35:315-323.
  • Griffiths R. The biochemistry and pharmacology of excitatory sulfur-containing amino acids. Biochem Soc Trans. 1993;21:66-72.
  • Lipton SA, Kim WK, Choi YB, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-asparatate receptor. Proc Natl Acad Sci USA. 1997;94:5923-5928.
  • Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330:613-622.
  • Bettachi CJ, Kamen BA, Cush JJ. Post-methotrexate (MTX) CNS toxicity: symptom reduction with dextromethorphan. Arthritis Rheum. 1999;42:S236.
  • Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. A new HPLC method for the simultaneous determination of oxidized ad reduced plasma aminothiols using coulometric electrochemical detection. J Nutr Biochem. 1999;10:490-497.
  • Allen JC, Rosen G, Mehta BM, Horten B, Leukoencephalopathy following high-dose IV methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep. 1980;64:1261-1273.
  • Fritsch G, Urban C. Transient encephalopathy during the late course of treatment with high-dose methotrexate. Cancer. 1984;53:1849-1851.
  • Jaffe N, Takaue Y, Anzai T, Robertson R. Transient neurologic disturbances induced by high-dose methotrexate treatment. Cancer. 1986;56:1356-1360.
  • Packer RJ, Grossman RI, Bellasco J. High dose systemic methotrexate-associated acute neurologic dysfunction. Med Pediatr Oncol. 1983;11:159-161.
  • Walker RW, Allen JC, Rosen G, Caparros B. Transient cerebral dysfunction secondary to high-dose methotrexate. J Clin Oncol.1986;4:1845-1850.
  • Butler RW, Hill JM, Steinherz PG, Meyers PA, Finlay JL. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol. 1994;12:2621-2629.
  • Gay CT, Bodensteiner JB, Nitschke R, Sexauer C, Wilson D. Reversible treatment-related leukoencephalopathy. J Child Neurol. 1989;4:208-213.
  • Rowland JH, Glidewell OJ, Sibley RF, et al. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. J Clin Oncol. 1984;2:1327-1335.
  • Refsum H, Helland S, Ueland PM. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patientsreceiving low-dose methotrexate treatment. Clin Pharmacol Ther. 1989;46:510-520.
  • Regland B, Andersson M, Abrahamsson L, Bagby J, Dyrehag LE, Gottfries CG. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol. 1997;26:301-307.
  • Guenod M, Grandes P, Zangerle L, Streit P, Do KQ. sulphur-containing excitatory amino acids in intercellular communication. Biochem Soc Trans. 1993;21:72-77.
  • Turski WA. Homocysteic acid: convulsant action of stereoisomers in mice. Brain Res. 1989;479:371-373.
  • Bridges RJ, Hatalski CG, Shim SN, et al. Gliotoxic actions of excitatory amino acids. Neuropharmacology 1992;64:899-907.
  • Croucher MJ, Collins JF, Meldrum BS. Anticonvulsant action of excitatory amino acid antagonsists. Science. 1982;216:899-901.
  • Meldrum B, Millan M, Patel S, de Sarro G. Antiepileptic effects of focal microinjection of excitatory amino acid antagonists. J Neural Transm. 1988;72:191-200.
  • Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of S-adenosylhomocysteine (SAM) in neurological disorders. Drugs. 1994;48:137-152.
  • Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocyteine and lymphocyte DNA hypomethylation. J Biol Chem. 2000;275:2918-2923.
  • Kishi T, Tanaka Y, Ueda K. Evidence for hypomethylation in two children with acute lymphoblastic leukemia and leukoencephalopathy. Cancer 2000;89:925-931.
  • Bernini JCB, Fort DW, Griener JC, Kane BJ, Chappell WB, Kamen BA. Aminophylline for methotrexate-induced neurotoxicity. Lancet. 1995;345:544-547.
  • Wang H, Yoshizumi M, Lai K, et al. Inhibition of growth and p21RAS methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem. 1997;272:25380-25385.
  • Winter-Vann AM, Kamen BA, Casey PJ. A novel pathway for cell growth inhibition by methotrexate. Proc Am Assoc Cancer Res. 2001;42:296.
  • Darboe MN, Keenan GR Jr. Richards TK. The abuse of DM-based cough syrup: a pilot study of the community of Waynesboro, Pennsylvania. Adolescence. 1993;31:633-644.
  • Darboe MN. Abuse of DM-based cough syrup as a substitute for licit and illicit drugs: a theoretical framework. Adolescence. 1996;31:239-245.
  • Murray S, Brewerton T. Abuse of over-the-counter dextromethorphan by teenagers. Southern Med. J. 1993:86:1151-1153.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.